Cue Biopharma SG&A Expense (TTM) Analysis

Cue Biopharma Inc (CUE)

0.6794 +0.23 (+49.61%) USD | NASDAQ | Sep 27, 16:00

0.70 +0.02 (+3.03%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	15.95M
March 31, 2024	16.69M
December 31, 2023	16.68M
September 30, 2023	15.77M
June 30, 2023	15.66M
March 31, 2023	15.19M
December 31, 2022	16.17M
September 30, 2022	17.11M
June 30, 2022	17.71M
March 31, 2022	18.21M
December 31, 2021	17.31M
September 30, 2021	16.18M
June 30, 2021	15.35M
March 31, 2021	14.97M
December 31, 2020	14.70M

Date	Value
September 30, 2020	14.34M
June 30, 2020	13.80M
March 31, 2020	13.39M
December 31, 2019	12.84M
September 30, 2019	14.16M
June 30, 2019	14.30M
March 31, 2019	13.04M
December 31, 2018	11.30M
September 30, 2018	8.248M
June 30, 2018	6.382M
March 31, 2018	5.148M
December 31, 2017	4.334M
September 30, 2017	3.692M
June 30, 2017	3.286M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

12.84M

Minimum

Dec 2019

18.21M

Maximum

Mar 2022

15.61M

Average

15.72M

Median

SG&A Expense (TTM) Benchmarks